[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336421-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336421-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","in-vivo-crispr-screening-identifies-geranylgeranyl-diphosphate-as-a-pancreatic-cancer-tumor-growth-dependency","In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency","","Objective: Cancer cells rely on lipid supply for proliferation by activating SREBP-driven lipid homeostasis programs, yet which SREBP target genes are essential for pancreatic ductal adenocarcinoma (PDAC) tumorigenesis remains unclear. Methods: A custom CRISPR knockout library of known SREBP targets was tested in vitro and in vivo using patient-derived PDAC cells and orthotopic xenografts, comparing lipid environments. Results: Terpenoid backbone genes are essential, with GGPP identified as required for tumor growth; mevalonate pathway restriction synergizes with SREBP inhibition to trigger apoptosis and alter prenylation, and GGPS1 knockdown reduces tumor burden. Conclusions: PDAC selectively depends on GGPP over other lipids, revealing a targetable vulnerability.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/in-vivo-crispr-screening-identifies-geranylgeranyl-diphosphate-as-a-pancreatic-cancer-tumor-growth-dependency/336421/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/in-vivo-crispr-screening-identifies-geranylgeranyl-diphosphate-as-a-pancreatic-cancer-tumor-growth-dependency/336421.png","ImageObject",300,407,{"name":42,"@type":43},"Maeve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main objective regarding SREBP in pancreatic cancer?","Question",{"text":63,"@type":64},"To determine which SREBP target genes are required for PDAC tumor growth and tumorigenesis, clarifying an essential gap in understanding SREBP-based therapeutic targeting.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers test SREBP target gene essentiality?",{"text":68,"@type":64},"They constructed a custom CRISPR knockout library of known SREBP target genes and performed both in vitro 2D culture screens and in vivo orthotopic xenograft CRISPR screens using patient-derived PDAC cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What lipid was identified as essential for PDAC tumor development?",{"text":72,"@type":64},"Geranylgeranyl diphosphate (GGPP), a nonsterol isoprenoid product of the mevalonate pathway, was identified as an essential lipid for tumor growth.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336421,1790495315,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Original article  \nIn vivo CRISPR screening identiﬁes geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency  \nCasie S. Kubota1, Stephanie L. Myers1,2, Toni T. Seppälä3, Richard A. Burkhart3, Peter J. Espenshade1, 4, 5, *  \nABSTRACT  \nObjective: Cancer cells must maintain lipid supplies for their proliferation and do so by upregulating lipogenic gene programs. The sterol regulatory element-binding proteins (SREBPs) act as modulators of lipid homeostasis by acting as transcriptional activators of genes required for fatty acid and cholesterol synthesis and uptake. SREBPs have been recognized as chemotherapeutic targets in multiple cancers, however it is not well understood which SREBP target genes are essential for tumorigenesis. In this study, we examined the requirement of SREBP target genes for pancreatic ductal adenocarcinoma (PDAC) tumor growth.  \nMethods: Here we constructed a custom CRISPR knockout library containing known SREBP target genes and performed in vitro 2D culture and in vivo orthotopic xenograft CRISPR screens using a patient-derived PDAC cell line. In vitro, we grew cells in medium supplemented with 10% fetal bovine serum (FBS) or 10% lipoprotein-deﬁcient serum (LPDS) to examine differences in gene essentiality in different lipid environments. In vivo, we injected cells into the pancreata of nude mice and collected tumors after 4 weeks.  \nResults: We identiﬁed terpenoid backbone biosynthesis genes as essential for PDAC tumor development. Speciﬁcally, we identiﬁed the nonsterol isoprenoid product of the mevalonate pathway, geranylgeranyl diphosphate (GGPP), as an essential lipid for tumor growth. Mechanistically, we observed that restricting mevalonate pathway activity using statins and SREBP inhibitors synergistically induced apoptosis and caused disruptions in small G protein prenylation that have pleiotropic effects on cellular signaling pathways. Finally, we demonstrated that geranylgeranyl diphosphate synthase 1 (GGPS1) knockdown signiﬁcantly reduces tumor burden in an orthotopic xenograft mouse model. Conclusions: These ﬁndings indicate that PDAC tumors selectively require GGPP over other lipids such as cholesterol and fatty acids and that this is a targetable vulnerability of pancreatic cancer cells.  \n􀀁 2024 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)) .  \nKeywords Lipid metabolism; Pancreatic cancer; SREBP; GGPP  \n1. INTRODUCTION  \nLipids support cell growth and proliferation by serving as structural components of membranes, energy sources, signaling molecules, and protein modiﬁcations. Under conditions of nutrient stress, tissues adapt to maintain normal cellular function. Cellular lipid homeostasis is maintained by the sterol regulatory element-binding protein (SREBP) class of transcription factors [1,2] . When cellular lipids are limiting, ERresident SREBPs are trafﬁcked to the Golgi by the SREBP cleavage activating protein (SCAP) . SREBPs are then activated by proteolytic cleavage and upregulate the transcription of lipid metabolic genes responsible for cholesterol and fatty acid synthesis and uptake such as low-densitylipoprotein receptor(LDLR), stearoyl-CoA desaturase(SCD), and HMG-CoA reductase (HMGCR). Two genes, SREBF1 and SREBF2, encode three isoforms, SREBP-1a, SREBP-1c, and SREBP-2, with  \ndistinct gene programs. SREBP-1 is generally responsible for upregulating fatty acid synthesis, while SREBP-2 controls cholesterol synthesis and uptake [3] . Lipid metabolic reprogramming has been implicated asan important facet of tumor metabolism, prompting the hypothesis that SREBPs may be an effective target for cancer therapy [4 ,5] .  \nPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest forms of cancer with a 5-year survival rate of 12%[6] . Poor patient prognosis is due to both late diagnosis as well as limited treat","cbCaijzY3xhHmggv","https://ap.wps.com/l/cbCaijzY3xhHmggv","pdf",2226934,11,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Lipid homeostasis and SREBP regulation\n## PDAC background and genetic drivers","[{\"question\":\"What was the study’s main objective regarding SREBP in pancreatic cancer?\",\"answer\":\"To determine which SREBP target genes are required for PDAC tumor growth and tumorigenesis, clarifying an essential gap in understanding SREBP-based therapeutic targeting.\"},{\"question\":\"How did the researchers test SREBP target gene essentiality?\",\"answer\":\"They constructed a custom CRISPR knockout library of known SREBP target genes and performed both in vitro 2D culture screens and in vivo orthotopic xenograft CRISPR screens using patient-derived PDAC cells.\"},{\"question\":\"What lipid was identified as essential for PDAC tumor development?\",\"answer\":\"Geranylgeranyl diphosphate (GGPP), a nonsterol isoprenoid product of the mevalonate pathway, was identified as an essential lipid for tumor growth.\"}]","In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency | PDF",1790014965,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b599d1fb12e9b0c2aa5045c85dfc18d.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb3364e4b419f3688fa72a9b65f1a23f.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c939e4ed6389c54cb47e4dd172efedcf.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97f00b2ad32953f6ea0c6bf8ef04b87d.webp",980,1306]